Analysis of the protein network of cholesterol homeostasis in different brain regions: An age and sex dependent perspective

Journal of Cellular Physiology

Volumn 228, Issue 7, 2013, Pages 1561-1567

  Segatto, Marco ^a   Di Giovanni, Annalaura ^a   Marino, Maria ^a   Pallottini, Valentina ^a  

^a ROMA TRE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; BRAIN PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

AGE; AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN REGION; BRAIN STEM; CEREBELLUM; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CYTOARCHITECTURE; FEMALE; HIPPOCAMPUS; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE; WHITE MATTER;

AGING; ANIMALS; BRAIN; BRAIN STEM; CEREBELLUM; CEREBRAL CORTEX; CHOLESTEROL; FEMALE; HIPPOCAMPUS; HOMEOSTASIS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; MALE; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; RATS; RATS, WISTAR; RECEPTORS, LDL; SEX CHARACTERISTICS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TISSUE DISTRIBUTION;

RATTUS;

EID: 84875483249     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24315     Document Type: Article

References (45)

1. Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, Dartigues JF, Kragh-Sorensen P, Baldereschi M, Brayne C, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A. 1999. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 53: 1992-1997.
2. Baytan SH, Alkanat M, Okuyan M, Ekinci M, Gedikli E, Ozeren M, Akgun A. 2008. Simvastatin impairs spatial memory in rats at a specific dose level. Tohoku J Exp Med 214: 341-349.
3. Bjorkhem I, Meaney S. 2004. Brain cholesterol: Long secret life behind a barrier. Arterioscler Thromb Vasc Biol 24: 806-815.
4. Block RC, Dorsey ER, Beck CA, Brenna JT, Shoulson I. 2010. Altered cholesterol and fatty acid metabolism in Huntington disease. J Clin Lipidol 4: 17-23.
5. Bodovitz S, Klein WL. 1996. Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J Biol Chem 271: 4436-4440.
6. Brown MS, Goldstein JL. 1997. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 331-340.
7. Brown MS, Goldstein JL. 1999. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA 96: 11041-11048.
8. Butcher RL, Collins WE, Fugo NW. 1974. Plasma concentration of LH, FSH, prolactin, progesterone, and estradiol-17 beta throughout the 4-day estrous cycle of the rat. Endocrinology 94: 1704-1708.
9. Callahan M, Lipinski W, Bian F, Durham R, Pack A, Walker L. 2001. Augmented senile plaque load in aged female beta amyloid precursor protein-transgenic mice. Am J Pathol 158: 1173-1177.
10. Cao D, Fukuchi K, Wan H, Kim H, Li L. 2006. Lack of LDL receptor aggravetes learning deficits and amyloid deposits in Alzheimer transgenic mice. Neurobiol Ageing 27: 1632-1643.
11. Cummings RD, Kornfeld S, Schneider WJ, Hobgood KK, Tolleshaug H, Brown MS, Goldstein JL. 1983. Biosynthesis of N- and O-linked oligosaccharides of the low-density lipoprotein receptor. J Biol Chem 258: 15261-15273.
12. De Marinis E, Martini C, Trentalance A, Pallottini V. 2008. Sex differences in hepatic regulation of cholesterol homeostasis. J Endocrinol 198: 635-643.
13. Dietschy JM, Turley SD. 2004. Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45: 1375-1397.
14. Espenshade PJ, Hughes AL. 2007. Regulation of sterol synthesis in eukaryotes. Annu Rev Genet 41: 401-427.
15. Filipovic I. 1989. Effect of inhibiting N-glycosylation on the stability and binding activity of the low-density lipoprotein receptor. J Biol Chem 264: 8815-8820.
16. Frears ER, Stephens DJ, Walters CE, Davies H, Austen BM. 1999. The role of cholesterol in the biosynthesis of beta-amyloid. Neuroreport 10: 1699-1705.
17. Goldstein JL, Brown MS. 1990. Regulation of the mevalonate pathway. Nature 343: 425-430.
18. Golomb BA, Kane T, Dimsdale JE. 2004. Severe irritability associated with statin cholesterol-lowering drugs. QJM 97: 229-235.
19. Keller GA, Barton MC, Shapiro DJ, Singer SJ. 1985. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase is present in peroxisomes in normal rat liver cells. Proc Natl Acad Sci USA 82: 770-774.
20. Lebron-Milad K, Milad MR. 2012. Sex differences, gonadal hormones and the fear extinction network: Implications for anxiety disorders. Biol Mood Anxiety Disord 2: 3.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
22. Malik B, Fernandes C, KilliK R, Wroe R, Usardi A, Williamson R, Kellie S, Anderton BH, Reynolds CH. 2012. Oligomeric amyloid-beta peptide affects the expression of genes involved in steroid and lipid metabolism in primary neurons. Neurochem Int 61: 321-333.
23. Marino M, Masella R, Bulzomi P, Campesi I, Malorni W, Franconi F. 2011. Nutrition and human health from a sex-gender perspective. Mol Aspects Med 32: 1-70.
24. Ohvo-Rekila H, Ramstedt B, Leppimaki P, Slotte JP. 2002. Cholesterol interactions with phospholipids in membranes. Prog Lipid Res 41: 66-97.
25. Pallottini V, Marino M, Cavallini G, Bergamini E, Trentalance A. 2003. Age-related changes of isoprenoid biosynthesis in rat liver and brain. Biogerontology 4: 371-378.
26. Pallottini V, Martini C, Bassi AM, Romano P, Nanni G, Trentalance A. 2006. Rat HMGCoA reductase activation in thioacetamide-induced liver injury is related to an increased reactive oxygen species content. J Hepatol 44: 368-374.
27. Pallottini V, Martini C, Cavallini G, Bergamini E, Mustard KJ, Hardie DG, Trentalance A. 2007. Age-related HMG-CoA reductase deregulation depends on ROS-induced p38 activation. Mech Ageing Dev 128: 688-695.
28. Pallottini V, Montanari L, Cavallini G, Bergamini E, Gori Z, Trentalance A. 2004. Mechanisms underlying the impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in aged rat liver. Mech Ageing Dev 125: 633-639.
29. Pepine CJ, Nichols WW, Pauly DF. 2006. Estrogen and different aspects of vascular disease in women and men. Circ Res 99: 459-461.
30. Pfrieger FW. 2002. Role of glia in synapse development. Curr Opin Neurobiol 12: 486-490.
31. Pfrieger FW. 2003. Role of cholesterol in synapse formation and function. Biochim Biophys Acta 1610: 271-280.
32. Reddy P, Krieger M. 1989. Isolation and characterization of an extragenic suppressor of the low-density lipoprotein receptor-deficient phenotype of a Chinese hamster ovary cell mutant. Mol Cell Biol 9: 4799-4806.
33. Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, Sambamurti K, Duff K, Pappolla MA. 2000. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 7: 321-331.
34. Repa JJ, Mangelsdorf DJ. 2000. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 16: 459-481.
35. Segatto M, Trapani L, Lecis C, Pallottini V. 2012. Regulation of cholesterol biosynthetic pathway in different regions of the rat central nervous system. Acta Physiol (Oxf) 206: 62-71.
36. Segatto M, Trapani L, Marino M, Pallottini V. 2011. Age- and sex-related differences in extra-hepatic low-density lipoprotein receptor. J Cell Physiol 226: 2610-2616.
37. Shie FS, Jin LW, Cook DG, Leverenz JB, LeBoeuf RC. 2002. Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice. Neuroreport 13: 455-459.
38. Swaab DF, Hofman MA. 1995. Sexual differentiation of the human hypothalamus in relation to gender and sexual orientation. Trends Neurosci 18: 264-270.
39. Tolleshaug H, Hobgood KK, Brown MS, Goldstein JL. 1983. The LDL receptor locus in familial hypercholesterolemia: Multiple mutations disrupt transport and processing of a membrane receptor. Cell 32: 941-951.
40. Trapani L, Pallottini V. 2010. Age-related hypercholesterolemia and HMG-CoA reductase dysregulation: Sex does matter (A gender perspective). Curr Gerontol Geriatr Res 2010: 1-7.
41. Trapani L, Segatto M, Simeoni V, Balducci V, Dhawan A, Parmar VS, Prasad AK, Saso L, Incerpi S, Pallottini V. 2011. Short- and long-term regulation of 3-hydroxy 3-methylglutaryl coenzyme A reductase by a 4-methylcoumarin. Biochimie 93: 1165-1171.
42. Trapani L, Violo F, Pallottini V. 2010. Hypercholesterolemia and 3-hydroxy-3-methylglutaryl coenzyme A reductase regulation in aged female rats. Exp Gerontol 45: 119-128.
43. Xiong H, Callaghan D, Jones A, Walker DG, Lue LF, Beach TG, Sue LI, Woulfe J, Xu H, Stanimirovic DB, Zhang W. 2008. Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production. Neurobiol Dis 29: 422-437.
44. Zipp F, Waiczies S, Aktas O, Neuhaus O, Hemmer B, Schraven B, Nitsch R, Hartung HP. 2007. Impact of HMG-CoA reductase inhibition on brain pathology. Trends Pharmacol Sci 28: 342-349.
45. Zlokovic BV, Deane R, Sagare AP, Bell RD, Winkler EA. 2010. Low density lipoprotein receptor-related protein-1: A serial clearance homeostatic mechanism controlling Alzheimer's amyloid beta peptide elimination from the brain. J Neurochem 115: 1077-1089.